Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
Surgical Science Sweden Community
OM:SUS Community
1
Narratives
written by author
0
Comments
on narratives written by author
17
Fair Values set
on narratives written by author
Community Investing Ideas
Surgical Science Sweden
Popular
Undervalued
Overvalued
Surgical Science Sweden
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
New Subscription Model With Intuitive And Asian Expansion Will Strengthen Future Prospects
Key Takeaways Strategic expansion into Asia and implementing a subscription-based model for recurring revenue could drive significant growth in revenue and net margins. Acquisitions and enhanced R&D and sales capabilities could position the company as a market leader with opportunities for synergistic revenue growth.
View narrative
SEK 172.00
FV
43.0% undervalued
intrinsic discount
20.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
SUS
SUS
Surgical Science Sweden
Your Fair Value
SEK
Current Price
SEK 98.00
39.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-7m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 2.1b
Earnings SEK 307.6m
Advanced
Set Fair Value